Semaglutide brands have different labeled uses
Ozempic contains semaglutide and is labeled for type 2 diabetes with specified additional risk-reduction indications. Wegovy also contains semaglutide and has weight-management indications, among other labeled uses. The current Wegovy label includes injections and oral tablets.
The ingredient name does not establish that doses, devices, routes or prescribing criteria are identical. Ask the clinician which product is proposed and why its indication and evidence fit your treatment goal.
Sources: Ozempic prescribing information · Wegovy prescribing information
Tirzepatide brands also need an indication check
Mounjaro and Zepbound contain tirzepatide, which acts at GIP and GLP-1 receptors. Mounjaro is labeled for type 2 diabetes in adults and children aged 10 years and older. Its August 2026 label also includes cardiovascular-event risk reduction in adults with type 2 diabetes who are at high risk for those events. Zepbound has weight reduction and maintenance indications in eligible adults and an indication for moderate-to-severe obstructive sleep apnea in adults with obesity.
Both approved products are injectable. Their trials do not establish the effectiveness of a compounded oral tirzepatide preparation. Do not substitute a marketed tablet or a vial for a branded device without a new prescription and product-specific instructions.
Sources: Mounjaro prescribing information · Zepbound prescribing information · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
Oral choices are now part of the comparison
Wegovy tablets have a morning fasting and waiting-period routine. Foundayo contains orforglipron, was approved in 2026, and can be taken with or without food. Each product has its own starting dose, escalation and interaction instructions. Their milligram strengths are not equivalents.
Choosing a route is a clinical and practical decision. Consider the full medicine list, the ability to follow the routine, tolerability, prescription eligibility and the maintenance cost. Convenience alone does not establish comparative effectiveness for an individual.
Sources: Wegovy prescribing information · Foundayo prescribing information
Compare the evidence and full care plan
A defined trial average is not an individual guarantee, and separate studies can involve different populations and treatment conditions. Avoid comparing a compounded product’s price with an approved product’s trial result as though both refer to the same preparation.
Review contraindications, precautions, expected follow-up and the complete bill. Prescribed weight-management medicine can be part of long-term treatment; discuss continuation and what happens if it is interrupted or stopped. This revised page contains no fictional personal medication comparison.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · Wegovy prescribing information · Zepbound prescribing information · Foundayo prescribing information · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA